Covestor
KYMR icon

Covestor’s Kymera Therapeutics KYMR Stock Holding History

Covestor’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11K Sell
102
-28
-22% -$3.21K 0.01% 1397
2026
Q2 		$15K Buy
130
+16
+14% +$1.38K 0.01% 1303
2026
Q1 		$10K Buy
114
+110
+2,750% +$8.71K 0.01% 1405
2025
Q4 		$0 Hold
4
– – ﹤0.01% 2512
2025
Q3 		$0 Hold
4
– – ﹤0.01% 2530
2025
Q2 		$0 Sell
4
-29
-88% -$999 ﹤0.01% 2485
2025
Q1 		$1K Buy
33
+30
+1,000% +$1.09K ﹤0.01% 2019
2024
Q4 		$0 Hold
3
– – ﹤0.01% 2496
2024
Q3 		$0 Sell
3
-1
-25% -$44 ﹤0.01% 2481
2024
Q2 		$0 Hold
4
– – ﹤0.01% 2499
2024
Q1 		$0 Hold
4
– – ﹤0.01% 2499
2023
Q4 		$0 Sell
4
-1
-20% -$18 ﹤0.01% 2435
2023
Q3 		$0 Sell
5
-1
-17% -$20 ﹤0.01% 2417
2023
Q2 		$0 Hold
6
– – ﹤0.01% 2407
2023
Q1 		$0 Hold
6
– – ﹤0.01% 2317
2022
Q4 		$0 Hold
6
– – ﹤0.01% 2341
2022
Q3 		$0 Sell
6
-1
-14% -$26 ﹤0.01% 2309
2022
Q2 		$0 Hold
7
– – ﹤0.01% 2146
2022
Q1 		$0 Sell
7
-2
-22% -$84 ﹤0.01% 2281
2021
Q4 		$1K Buy
+9
New +$524 ﹤0.01% 1812

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Covestor's KYMR Position: Q3 2026 in Review

Covestor reduced its Kymera Therapeutics (KYMR) stake by 22% in Q3 2026, selling an estimated $3.21K and leaving 102 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #1397.

Covestor first reported a position in KYMR in Q4 2021 and has held it in 20 quarters since. The position peaked at $15K in Q2 2026. 215 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • Covestor held 102 shares of Kymera Therapeutics worth $11K as of Q3 2026.
  • Covestor sold 28 Kymera Therapeutics shares in Q3 2026, an estimated $3.21K.
  • Kymera Therapeutics made up 0.01% of Covestor's portfolio in Q3 2026, its #1397 holding.
  • Covestor first reported a position in Kymera Therapeutics in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Kymera Therapeutics position peaked at $15K in Q2 2026.
  • 215 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.